These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Psychophysiological dysfunctions in the developmental course of schizophrenic disorders. Dawson ME; Nuechterlein KH Schizophr Bull; 1984; 10(2):204-32. PubMed ID: 6729410 [TBL] [Abstract][Full Text] [Related]
5. What does electrodermal activity tell us about prognosis in the schizophrenia spectrum? Dawson ME; Schell AM Schizophr Res; 2002 Mar; 54(1-2):87-93. PubMed ID: 11853982 [TBL] [Abstract][Full Text] [Related]
7. Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress. Nuechterlein KH; Dawson ME; Gitlin M; Ventura J; Goldstein MJ; Snyder KS; Yee CM; Mintz J Schizophr Bull; 1992; 18(3):387-425. PubMed ID: 1411329 [TBL] [Abstract][Full Text] [Related]
8. Season of birth and electrodermal unresponsiveness in male schizophrenics. Ohlund LS; Ohman A; Alm T; Ost LG; Lindström LH Biol Psychiatry; 1990 Feb; 27(3):328-40. PubMed ID: 2302440 [TBL] [Abstract][Full Text] [Related]
9. Electrodermal and vascular orienting response in schizophrenic patients: relationship to symptoms and medication. Schlenker R; Cohen R; Hubmann W; Mohr F; Wahlheim C; Watzl H; Werther P Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):152-8. PubMed ID: 7669822 [TBL] [Abstract][Full Text] [Related]
10. Electrodermal activity and social network as predictors of outcome of episodes in schizophrenia. Hultman CM; Ohlund LS; Wieselgren IM; Ohman A; Ost LG J Abnorm Psychol; 1996 Nov; 105(4):626-36. PubMed ID: 8952196 [TBL] [Abstract][Full Text] [Related]
11. Electrodermal activity as a predictor of schizophrenic relapse. Tarrier N; Barrowclough C Psychopathology; 1989; 22(6):320-4. PubMed ID: 2639381 [TBL] [Abstract][Full Text] [Related]
12. Electrodermal activity and obstetric complications in schizophrenia. Ohman A; Hultman CM J Abnorm Psychol; 1998 May; 107(2):228-37. PubMed ID: 9604552 [TBL] [Abstract][Full Text] [Related]
13. The relationship of symptomatology and medication to electrodermal activity in schizophrenia. Green MF; Nuechterlein KH; Satz P Psychophysiology; 1989 Mar; 26(2):148-57. PubMed ID: 2567035 [TBL] [Abstract][Full Text] [Related]
14. Electrodermal activation in first-episode psychotic patients and their first-degree relatives. Iacono WG; Ficken JW; Beiser M Psychiatry Res; 1999 Oct; 88(1):25-39. PubMed ID: 10641584 [TBL] [Abstract][Full Text] [Related]
15. Electrodermal orienting response and central nervous system dopamine and serotonin activity in schizophrenia. Ohlund LS; Lindström LH; Ohman A J Nerv Ment Dis; 1992 May; 180(5):304-13. PubMed ID: 1374792 [TBL] [Abstract][Full Text] [Related]
16. Electrodermal responsiveness, clinical variables, and brain imaging in male chronic schizophrenics. Kim DK; Shin YM; Kim CE; Cho HS; Kim YS Biol Psychiatry; 1993 Jun 1-15; 33(11-12):786-93. PubMed ID: 8373916 [TBL] [Abstract][Full Text] [Related]
17. Early parental death: relation to electrodermal orienting response and gender in schizophrenia. Ohlund LS; Hultman CM Schizophr Res; 1992 Jul; 7(2):125-33. PubMed ID: 1515373 [TBL] [Abstract][Full Text] [Related]
18. The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects. Schell AM; Dawson ME; Nuechterlein KH; Subotnik KL; Ventura J Psychophysiology; 2002 Mar; 39(2):124-32. PubMed ID: 12212661 [TBL] [Abstract][Full Text] [Related]
19. Relationships between electrodermal activity and symptomatology in schizophrenia. Fuentes I; García Merita M; Miquel M; Rojo J Psychopathology; 1993; 26(1):47-52. PubMed ID: 8511230 [TBL] [Abstract][Full Text] [Related]
20. Electrodermal activity in schizophrenia: a quantitative study using a short interstimulus paradigm. Lim CL; Gordon E; Harris A; Bahramali H; Li WM; Manor B; Rennie C Biol Psychiatry; 1999 Jan; 45(1):127-35. PubMed ID: 9894584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]